NCT04232774 - Neurotronic Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 4, 2019

Primary Completion Date

January 17, 2023

Study Completion Date

January 17, 2023

Conditions

Type 2 Diabetes Mellitus With Circulatory Complciation

Interventions

DEVICE

The Neurotronic arterial ablation catheter

a sterile, single use catheter (device) for delivering chemical agent to achieve perivascular denervation.

Trial Locations (1)

Sanatorio Italiano - Centro de Intervenciones Endovasculares, Asunción